InsiderTrades

Form 4 for HRMY Harmony Biosciences Holdings, Inc.

Accepted 2025-10-02 00:00:00 ET · period of report 2025-09-30 · accession 0001677141-25-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-10-02 2025-09-30 HRMY Kapadia Sandip CFO M - OptEx $0.00 +45.0K 45.0K New $0
D 2025-10-02 2025-09-30 HRMY Kapadia Sandip CFO F - Tax $27.56 -24.0K 21.0K -53% -$662.5K
D 2025-10-02 2025-09-30 HRMY Kapadia Sandip CFO M - OptEx $0.00 -45.0K 45.0K -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-09-30 M A 45,000 $0.00 45,000 D — —
2 Common Common Stock 2025-09-30 F D 24,039 $27.56 20,961 D — — (F1) Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.
3 Derivative Restricted Stock Units 2025-09-30 M D 45,000 $0.00 45,000 D — · — to — 45,000 Common Stock (F2) The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.